Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report) was the target of a large increase in short interest during the month of May. As of May 15th, there was short interest totaling 8,438 shares, an increase of 130.9% from the April 30th total of 3,655 shares. Based on an average daily trading volume, of 8,905 shares, the days-to-cover ratio is currently 0.9 days.
Wall Street Analysts Forecast Growth
Separately, Zacks Research downgraded Carl Zeiss Meditec from a “hold” rating to a “strong sell” rating in a research report on Monday, May 25th. One analyst has rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold”.
Check Out Our Latest Report on Carl Zeiss Meditec
Carl Zeiss Meditec Price Performance
About Carl Zeiss Meditec
Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.
The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.
Recommended Stories
- Five stocks we like better than Carl Zeiss Meditec
- Burlington Beat Earnings Estimates, But Not Investor Expectations
- Palantir Stock Faces Technical Pressure Despite Strong AI Growth
- These 3 CLO ETFs Target a Niche Corner of the Fixed-Income Market
- 3 Ways to Play the Data Center Land Grab
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
